Carol Conrad1, David N Cornfield. 1. aDivision of Pediatric Pulmonary Medicine bDivision of Critical Care, Department of Pediatrics, Center for Excellence in Pulmonary Biology, Lucile Packard Children's Hospital, Stanford University School of Medicine, Stanford, California, USA.
Abstract
PURPOSE OF REVIEW: Lung transplantation for infants and children is an accepted but rarely exercised option for the treatment of end-stage lung disease, with outcomes equivalent to those for adults. However, widespread misconceptions regarding pediatric outcomes often confound timely and appropriate referral to specialty centers. We present the updated information for primary pediatricians to utilize when counseling families with children confronted by progressive end-stage pulmonary or cardiovascular disease. RECENT FINDINGS: We provide general guidelines to consider for referral, and discuss allocation of organs in children, information regarding standard treatment protocols, and survival outcomes. SUMMARY: Lung transplantation is a worthwhile treatment option to consider in children with end-stage lung disease. The treatment is complex, but lung transplant provides substantial survival benefit and markedly improved quality of life for children and their families. This timely review provides comprehensive information for pediatricians who are considering options for treatment of children with end-stage lung disease.
PURPOSE OF REVIEW: Lung transplantation for infants and children is an accepted but rarely exercised option for the treatment of end-stage lung disease, with outcomes equivalent to those for adults. However, widespread misconceptions regarding pediatric outcomes often confound timely and appropriate referral to specialty centers. We present the updated information for primary pediatricians to utilize when counseling families with children confronted by progressive end-stage pulmonary or cardiovascular disease. RECENT FINDINGS: We provide general guidelines to consider for referral, and discuss allocation of organs in children, information regarding standard treatment protocols, and survival outcomes. SUMMARY: Lung transplantation is a worthwhile treatment option to consider in children with end-stage lung disease. The treatment is complex, but lung transplant provides substantial survival benefit and markedly improved quality of life for children and their families. This timely review provides comprehensive information for pediatricians who are considering options for treatment of children with end-stage lung disease.
Authors: Varun Puri; Deirdre Epstein; Steven C Raithel; Sanjiv K Gandhi; Stuart C Sweet; Albert Faro; Charles B Huddleston Journal: J Thorac Cardiovasc Surg Date: 2010-06-09 Impact factor: 5.209
Authors: C Ashley Finlen Copeland; Laurie D Snyder; David W Zaas; W Jackson Turbyfill; W Austin Davis; Scott M Palmer Journal: Am J Respir Crit Care Med Date: 2010-05-27 Impact factor: 21.405
Authors: Geert M Verleden; Robin Vos; Stijn E Verleden; Walter De Wever; Stéphanie I De Vleeschauwer; Anna Willems-Widyastuti; Hans Scheers; Lieven J Dupont; Dirk E Van Raemdonck; Bart M Vanaudenaerde Journal: Transplantation Date: 2011-09-27 Impact factor: 4.939
Authors: Matthew R Morrell; George J Despotis; Douglas M Lublin; George A Patterson; Elbert P Trulock; Ramsey R Hachem Journal: J Heart Lung Transplant Date: 2009-10-22 Impact factor: 10.247
Authors: David M Hoganson; Avihu Z Gazit; Stuart C Sweet; R Mark Grady; Charles B Huddleston; Pirooz Eghtesady Journal: Ann Thorac Surg Date: 2013-02 Impact factor: 4.330
Authors: V A Starnes; M S Woo; E F MacLaughlin; M V Horn; P C Wong; J M Rowland; C L Durst; W J Wells; M L Barr Journal: Ann Thorac Surg Date: 1999-12 Impact factor: 4.330
Authors: Roy G Brower; Michael A Matthay; Alan Morris; David Schoenfeld; B Taylor Thompson; Arthur Wheeler Journal: N Engl J Med Date: 2000-05-04 Impact factor: 91.245
Authors: William J Steinbach; Kieren A Marr; Elias J Anaissie; Nkechi Azie; Shun-Ping Quan; Herwig-Ulf Meier-Kriesche; Senu Apewokin; David L Horn Journal: J Infect Date: 2012-08-13 Impact factor: 6.072